WEE1 and liver cancer: Given the gene’s pivotal role in cell growth, cell cycle regulation, migration, and invasion via the phosphatidyl 3-kinase/protein kinase signaling pathway, GPSM2 is proposed as an oncogene and therapeutic target in liver cancer [17,40].